Static Chart NFL Biosciences

Stocks

Real-time Euronext Paris 17:55:24 17/08/2026 +04			5-day change	1st Jan Change
0.8600 ^EUR	+3.37%		-0.69%	-26.99%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI

Duration

Period